Rapid test study could help doctors determine who needs COVID-19 booster shot wbal.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wbal.com Daily Mail and Mail on Sunday newspapers.
12 April, 2021
Nurses in all clinical settings need to be able to identify suspected deep vein thrombosis. This article explains the risk factors and how to clinically assess the leg.
Abstract
Nurses will increasingly have to identify and assess for deep vein thrombosis in both primary and secondary care, and so they need the skills to assess the clinical risk of the patient. This article explains how to: understand deep vein thrombosis in terms of its associated risk factors, use the two-level Wells score for estimating a patient’s risk, and carry out a leg assessment for a suspected deep vein thrombosis.
How AstraZeneca Blood Clot Risk Compares to Contraceptive Pill, Smoking, Long-Haul Flights
On 4/8/21 at 8:40 AM EDT
On Wednesday, the European Medicines Agency (EMA) stated that blood clots with low blood platelets should be listed as very rare side effects of the Oxford-AstraZeneca (AZ) COVID vaccine.
It came to its conclusion based on a review of 86 blood clotting cases reported in the EU drug safety database, 18 of which were fatal. Most of these cases were reported from the EU as well as the U.K., where roughly 25 million people have received the jab. The EMA added the benefits of the vaccine still outweigh the risks.
Researchers identify molecular link between inflammatory signaling molecule and a main oncogene
A team of MedUni Vienna researchers led by Johannes A. Schmid at the Center for Physiology and Pharmacology, Institute of Vascular Biology and Thrombosis Research, has managed to identify a previously unknown molecular connection between an inflammatory signaling molecule and one of the main oncogenes. The study has been published in the leading journal
Molecular Cancer .
Johannes A. Schmid s working group at the Center for Physiology and Pharmacology, Institute of Vascular Biology and Thrombosis Research, already has many years experience in the molecular and cellular aspects of inflammatory processes and is investigating what role these processes play in the development of cancer, as well as cardiovascular diseases.